Sequential treatment of HCC cells with PI3K Akt mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population

Kahraman D. C., Kahraman T., ATALAY R.

EACR 27, 1 - 04 July 2016, vol.61, pp.77

  • Publication Type: Conference Paper / Summary Text
  • Volume: 61
  • Doi Number: 10.1016/s0959-8049(16)61268-6
  • Page Numbers: pp.77
  • Middle East Technical University Affiliated: Yes